series-a
Stage
1
Investors
About
Tenvie develops precision-engineered small molecule therapies targeting neuroinflammation and cellular dysfunction to treat neurological and peripheral diseases with CNS-penetrant and peripherally restricted agents.
Explore Tenvie's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.